MicroRNAs对肿瘤相关巨噬细胞的趋化及表型的影响

彭妍 李国利 张艳青

彭妍, 李国利, 张艳青. MicroRNAs对肿瘤相关巨噬细胞的趋化及表型的影响[J]. 中国肿瘤临床, 2013, 40(2): 119-122. doi: 10.3969/j.issn.1000-8179.2013.02.015
引用本文: 彭妍, 李国利, 张艳青. MicroRNAs对肿瘤相关巨噬细胞的趋化及表型的影响[J]. 中国肿瘤临床, 2013, 40(2): 119-122. doi: 10.3969/j.issn.1000-8179.2013.02.015
Yan PENG, Guoli LI, Yanqing ZHANG. Effects of microRNAs on the chemotaxis and polarization of tumor-associated macrophage[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(2): 119-122. doi: 10.3969/j.issn.1000-8179.2013.02.015
Citation: Yan PENG, Guoli LI, Yanqing ZHANG. Effects of microRNAs on the chemotaxis and polarization of tumor-associated macrophage[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(2): 119-122. doi: 10.3969/j.issn.1000-8179.2013.02.015

MicroRNAs对肿瘤相关巨噬细胞的趋化及表型的影响

doi: 10.3969/j.issn.1000-8179.2013.02.015
基金项目: 

江苏省高校自然科学研究项目 12KJD320007

详细信息
    通讯作者:

    李国利  Lgl01012000@yahoo.com.cn

Effects of microRNAs on the chemotaxis and polarization of tumor-associated macrophage

Funds: 

Natural Science Research Project of Jiangsu Provincial Colleges and Universities 12KJD320007

More Information
  • 摘要: 单核-巨噬细胞是机体固有免疫反应的重要组成部分, 在肿瘤间质中浸润有大量巨噬细胞, 被称为肿瘤相关巨噬细胞(tumor-associated macrophage, TAM)。MicroRNAs(miRNAs, miRs)是一类由内源基因编码, 长度约为22个核苷酸的非编码单链RNA分子。miRNA与目标基因3'不翻译区(3'-UTR)结合, 抑制靶蛋白的表达, 在转录后水平对目标基因的表达水平进行调控。miRNAs可通过调控趋化因子及炎症因子影响巨噬细胞的趋化和分化。本文将近几年关于miRNAs对TAM的趋化及表型影响的研究结果进行综述。

     

  • [1] Allavena P, Sica A, Solinas G, et al. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages[J]. Crit Rev Oncol Hematol, 2008, 66(1): 1-9. doi: 10.1016/j.critrevonc.2007.07.004
    [2] Nakamachi Y, Kawano S, Takenokuchi M, et al. MicroRNA-124a isa key regulator of proliferation and monocyte chemoattractant protein1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis[J]. Arthritis Rheum, 2009, 60(5): 1294-1304. doi: 10.1002/art.24475
    [3] Strum JC, Johnson JH, Ward J, et al. MicroRNA 132 regulates nutritional stress-induced chemokine production through repression ofSirT1[J]. Mol Endocrinol, 2009, 23(11): 1876-1884. doi: 10.1210/me.2009-0117
    [4] Zhao X, Tang Y, Qu B, et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targetingKLF13 in systemic lupus erythematosus[J]. Arthritis Rheum, 2010, 62(11): 3425-3435. doi: 10.1002/art.27632
    [5] Lim PK, Bliss SA, Patel SA, et al. Gap junction-mediated import ofmicroRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells[J]. Cancer Res, 2011, 71(5): 1550-1560. doi: 10.1158/0008-5472.CAN-10-2372
    [6] Li C, Liu B, Dai Z, et al. Knockdown of VEGF receptor-1(VEGFR-1)impairs macrophage infiltration, angiogenesis and growth ofclear cell renal cell carcinoma(CRCC)[J]. Cancer Biol Ther, 2011, 12(10): 872-880. doi: 10.4161/cbt.12.10.17672
    [7] Linde N, Lederle W, Depner S, et al. Vascular endothelial growthfactor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages[J]. J Pathol, 2012, 227(1): 17-28. doi: 10.1002/path.3989
    [8] Fan L, Wu Q, Xing X, et al. MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells[J]. Acta Biochim Biophys Sin(Shanghai), 2012, 44(5): 407-414.
    [9] Yue X, Wang P, Xu J, et al. MicroRNA-205 functions as a tumorsuppressor in human glioblastoma cells by targeting VEGF-A[J]. Oncol Rep, 2012, 27(4): 1200-1206. doi: 10.3892/or.2011.1588
    [10] Worm J, Stenvang J, Petri A, et al. Silencing of microRNA-155 inmice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF[J]. Nucleic Acids Res, 2009, 37(17): 5784-5792. doi: 10.1093/nar/gkp577
    [11] Mandal CC, Ghosh-Choudhury T, Dey N, et al. miR-21 is TargetedBy Omega-3 Polyunsaturated Fatty Acid to Regulate Breast TumorCSF-1 Expression[J]. Carcinogenesis, 2012, 33(10): 1897-1908. doi: 10.1093/carcin/bgs198
    [12] Bandres E, Bitarte N, Arias F, et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation ofgastrointestinal cancer cells[J]. Clin Cancer Res, 2009, 15(7): 2281-2290. doi: 10.1158/1078-0432.CCR-08-1818
    [13] Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumourprogression: potential targets of anti-cancer therapy[J]. Eur J Cancer, 2006, 42(6): 717-727. doi: 10.1016/j.ejca.2006.01.003
    [14] Shim YJ, Kang BH, Choi BK, et al. Clusterin induces the secretionof TNF-αand the chemotactic migration of macrophages[J]. Biochem Biophys Res Commun, 2012, 422(1): 200-205. doi: 10.1016/j.bbrc.2012.04.162
    [15] Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 andmiR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxinshock[J]. J Immunol, 2007, 179(8): 5082-5089. doi: 10.4049/jimmunol.179.8.5082
    [16] El Gazzar M, Church A, Liu T, et al. MicroRNA-146a regulatesboth transcription silencing and translation disruption of TNF-αduring TLR4-induced gene reprogramming[J]. J Leukoc Biol, 2011, 90(3): 509-519. doi: 10.1189/jlb.0211074
    [17] Redente EF, Dwyer-Nield LD, Barrett BS, et al. Lung tumorgrowth is stimulated in IFN-gamma-/-mice and inhibited inIL-4Ralpha-/-mice[J]. Anticancer Res, 2009, 29(12): 5095-5101.
    [18] Lu TX, Hartner J, Lim EJ, et al. MicroRNA-21 limits in vivoimmune response-mediated activation of the IL-12/IFN-gammapathway, Th1 polarization, and the severity of delayed-typehypersensitivity[J]. J Immunol, 2011, 187(6): 3362-3373. doi: 10.4049/jimmunol.1101235
    [19] Trotta R, Chen L, Ciarlariello D, et al. miR-155 regulates IFN-γproduction in natural killer cells[J]. Blood, 2012, 119(15): 3478-3485. doi: 10.1182/blood-2011-12-398099
    [20] Liu Y, Chen Q, Song Y, et al. MicroRNA-98 negatively regulatesIL-10 production and endotoxin tolerance in macrophages afterLPS stimulation[J]. FEBS Lett, 2011, 585(12): 1963-1968. doi: 10.1016/j.febslet.2011.05.029
    [21] Merline R, Moreth K, Beckmann J, et al. Signaling by the matrixproteoglycan decorin controls inflammation and cancer throughPDCD4 and MicroRNA-21[J]. Sci. Signal, 2011, 4(199).
    [22] Fox SW, Haque SJ, Lovibond AC, et al. The possible role ofTGF-beta-induced suppressors of cytokine signaling expression inosteoclast/macrophage lineage commitment in vitro[J]. J Immunol, 2003, 170(7): 3679-3687. doi: 10.4049/jimmunol.170.7.3679
    [23] Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. MicroRNA-155targets SMAD2 and modulates the response of macrophages totransforming growth factor-{beta}[J]. J Biol Chem, 2010, 285(53): 41328-41336. doi: 10.1074/jbc.M110.146852
    [24] Jiang X, Xiang G, Wang Y, et al. MicroRNA-590-5p regulatesproliferation and invasion in human hepatocellular carcinoma cellsby targeting TGF-βRII[J]. Mol Cells, 2012, 33(6): 545-551. doi: 10.1007/s10059-012-2267-4
    [25] Chen T, Huang Z, Wang L, et al. MicroRNA-125a-5p partlyregulates the inflammatory response, lipid uptake, and ORP9expression in oxLDL-stimulated monocyte/macrophages[J]. Cardiovasc Res, 2009, 83(1): 131-139. doi: 10.1093/cvr/cvp121
    [26] Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The interleukin13(IL-13)pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1(IL13Ralpha1)[J]. J Biol Chem, 2011, 286(3): 1786-1794. doi: 10.1074/jbc.M110.169367
    [27] Galmbacher K, Heisig M, Hotz C, et al. Shigella mediated depletionof macrophages in a murine breast cancer model is associated withtumor regression[J]. PLoS One, 2010, 5(3): e9572. doi: 10.1371/journal.pone.0009572
    [28] Wang B, Li Q, Qin L, et al. Transition of tumor-associated macrophages from MHC class II(hi)to MHC class II(low)mediates tumor progression in mice[J]. BMC Immunol, 2011, 12: 43. doi: 10.1186/1471-2172-12-43
    [29] Cai X, Yin Y, Li N, et al. Re-polarization of tumor-associated macrophages to pro-inflammatory 1 macrophages by microRNA-155[J]. J Mol Cell Biol, 2012, 4(5): 341-343. doi: 10.1093/jmcb/mjs044
  • 加载中
计量
  • 文章访问数:  15
  • HTML全文浏览量:  3
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-08-27
  • 修回日期:  2012-12-11

目录

    /

    返回文章
    返回